日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study.

评估超治疗剂量的inclisiran对健康志愿者心脏复极化的影响：一项 I 期随机研究

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13391
Kallend David, Mason Jay, Smith Patrick F, Koren Michael J, Stoekenbroek Robert, He YanLing, Wijngaard Peter
其它
发表日期：2022
文献求助 收藏

Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial

剂或 2 剂 Inclisiran 对低密度脂蛋白胆固醇水平的影响：ORION-1 随机临床试验的一年随访

期刊:Jama Cardiology
影响因子:14.1
doi:10.1001/jamacardio.2019.3502
Ray, Kausik K; Stoekenbroek, Robert M; Kallend, David; Nishikido, Toshiyuki; Leiter, Lawrence A; Landmesser, Ulf; Wright, R Scott; Wijngaard, Peter L J; Kastelein, John J P
代谢
发表日期：2019
文献求助 收藏

Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial

在 MILANO-PILOT 试验中，输注含重组载脂蛋白 AI Milano 的高密度脂蛋白模拟物对急性冠脉综合征患者冠状动脉疾病的影响：一项随机临床试验

期刊:Jama Cardiology
影响因子:14.1
doi:10.1001/jamacardio.2018.2112
Nicholls, Stephen J; Puri, Rishi; Ballantyne, Christie M; Jukema, J Wouter; Kastelein, John J P; Koenig, Wolfgang; Wright, R Scott; Kallend, David; Wijngaard, Peter; Borgman, Marilyn; Wolski, Kathy; Nissen, Steven E
发表日期：2018
文献求助 收藏

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

一种高度持久的PCSK9 RNAi治疗抑制剂

期刊:New England Journal of Medicine
影响因子:78.5
doi:10.1056/NEJMoa1609243
Fitzgerald, Kevin; White, Suellen; Borodovsky, Anna; Bettencourt, Brian R; Strahs, Andrew; Clausen, Valerie; Wijngaard, Peter; Horton, Jay D; Taubel, Jorg; Brooks, Ashley; Fernando, Chamikara; Kauffman, Robert S; Kallend, David; Vaishnaw, Akshay; Simon, Amy
PCSK9
CSK
发表日期：2017
文献求助 收藏

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size

将 MDCO-216 (ApoA-IMilano/POPC) 与人血清孵育可增强 ABCA1 介导的胆固醇外流能力，生成新的前β-1 HDL，并导致 HDL 颗粒增大。

期刊:Journal of Lipids
影响因子:5.9
doi:10.1155/2014/923903
Kempen, Herman J; Schranz, Dorota B; Asztalos, Bela F; Otvos, James; Jeyarajah, Elias; Drazul-Schrader, Denise; Collins, Heidi L; Adelman, Steven J; Wijngaard, Peter L J
Human
发表日期：2014
文献求助 收藏

Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys

重复输注apoA-IMilano/POPC对食蟹猴脂质、（载脂）脂蛋白和血清胆固醇外流能力的影响

期刊:Journal of Lipid Research
影响因子:4.1
doi:10.1194/jlr.M033779
Kempen, Herman J; Gomaraschi, Monica; Bellibas, S Eralp; Plassmann, Stephanie; Zerler, Brad; Collins, Heidi L; Adelman, Steven J; Calabresi, Laura; Wijngaard, Peter L J
代谢
发表日期：2013
文献求助 收藏